Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
8-17-2021

Association between diagnosis code expansion and changes in
30-day risk-adjusted outcomes for cardiovascular diseases
Lauren Gilstrap
Dartmouth College

Rishi K Wadhera
Beth Israel Deaconess Medical Center

Andrea M Austin
Dartmouth College

Stephen Kearing
Dartmouth-Hitchcock Medical Center

Karen E Joynt Maddox
Washington University School of Medicine

See next page for additional authors

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Gilstrap, Lauren; Wadhera, Rishi K; Austin, Andrea M; Kearing, Stephen; Joynt Maddox, Karen E; and Yeh,
Robert W, ,"Association between diagnosis code expansion and changes in 30-day risk-adjusted
outcomes for cardiovascular diseases." Journal of the American Heart Association. 10,16. . (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10706

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Authors
Lauren Gilstrap, Rishi K Wadhera, Andrea M Austin, Stephen Kearing, Karen E Joynt Maddox, and Robert W
Yeh

This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/
open_access_pubs/10706
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ORIGINAL RESEARCH

Association Between Diagnosis Code
Expansion and Changes in 30-Day Risk-
Adjusted Outcomes for Cardiovascular
Diseases
Lauren Gilstrap , MD, MPH; Rishi K. Wadhera , MD, MPP; Andrea M. Austin, PhD;
Stephen Kearing, MS; Karen E. Joynt Maddox , MD, MPH; Robert W. Yeh , MD, MBA
BACKGROUND: In January 2011, Centers for Medicare and Medicaid Services expanded the number of inpatient diagnosis codes
from 9 to 25, which may influence comorbidity counts and risk-adjusted outcome rates for studies spanning January 2011.
This study examines the association between (1) limiting versus not limiting diagnosis codes after 2011, (2) using inpatient-only
versus inpatient and outpatient data, and (3) using logistic regression versus the Centers for Medicare and Medicaid Services
risk-standardized methodology and changes in risk-adjusted outcomes.

Downloaded from http://ahajournals.org by on September 9, 2021

METHODS AND RESULTS: Using 100% Medicare inpatient and outpatient files between January 2009 and December 2013, we
created 2 cohorts of fee-for-service beneficiaries aged ≥65 years. The acute myocardial infarction cohort and the heart failure
cohort had 578 728 and 1 595 069 hospitalizations, respectively. We calculate comorbidities using (1) inpatient-only limited
diagnoses, (2) inpatient-only unlimited diagnoses, (3) inpatient and outpatient limited diagnoses, and (4) inpatient and outpatient unlimited diagnoses. Across both cohorts, International Classification of Diseases, Ninth Revision (ICD-9) diagnoses and
hierarchical condition categories increased after 2011. When outpatient data were included, there were no significant differences in risk-adjusted readmission rates using logistic regression or the Centers for Medicare and Medicaid Services risk
standardization. A difference-in-differences analysis of risk-adjusted readmission trends before versus after 2011 found that
no significant differences between limited and unlimited models for either cohort.
CONCLUSIONS: For studies that span 2011, researchers should consider limiting the number of inpatient diagnosis codes to
9 and/or including outpatient data to minimize the impact of the code expansion on comorbidity counts. However, the 2011
code expansion does not appear to significantly affect risk-adjusted readmission rate estimates using either logistic or risk-
standardization models or when using or excluding outpatient data.
Key Words: acute myocardial infarction ■ heart failure ■ medicare ■ outcomes

I

n January 2011, the Centers for Medicare and
Medicaid Services (CMS) expanded the number of
available secondary diagnosis codes from 9 to 25
for inpatient hospitalizations.1 Since then, 2 analyses
have suggested that not accounting for this expansion
in diagnosis codes may bias comorbidity counts and
estimates of risk-adjusted readmission rates.2,3 Another

analysis found that this expansion was associated with a
statistically significant increase in the measured severity
of illness among diagnoses targeted by readmission-
based incentive programs.4 This has led some to advocate for limiting the number of diagnostic codes after
January 2011 to 9,3,5 whereas others have argued that
there is no need to limit diagnosis codes if outpatient
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CLINICAL PERSPECTIVE
What Is New?

• In January 2011, the Centers for Medicare and
Medicaid Services expanded the number of inpatient diagnosis codes from 9 to 25; this had
led to concerns about the stability of comorbidity counts and risk-adjusted outcome rates for
studies that span 2011.
• To address this, some have recommend limiting
the number of inpatient diagnosis codes to 9
for studies that span 2011, whereas others have
recommended including outpatient data as a
way of mitigating the impact of the diagnosis
code expansion.
• In this study, we found an increase in comorbidity counts after 2011 but no significant difference in risk-adjusted outcomes rates between
models that limited the number of diagnosis
codes to 9 versus those that did not or between
models that used inpatient-only data versus inpatient and outpatient data.

What Are the Clinical Implications?
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• For studies that span 2011, diagnosis codes
may need to be limited for studies that use
comorbidity counts, but the 2011 code expansion does not appear to significantly affect
risk-adjusted readmission rate estimates using
either logistic or risk-standardization models.

Nonstandard Abbreviations and Acronyms
CMS
HCCs

Centers for Medicare and Medicaid
Services
hierarchical condition comorbidities

data are also included.6–8 At present, little is known
about the association between limiting versus not limiting diagnosis codes after 2011 and whether adding
outpatient data influences this for acute myocardial infarction (AMI) and heart failure (HF). Understanding the
associations between diagnosis code limits and data
sources with comorbidity assessment and estimates of
30-day risk-adjusted readmission rates is important in
comparing evaluations of policy interventions that span
January 2011, most notably the Hospital Readmissions
Reduction Program.9–12
Another factor to consider in comparing evaluations of
policy interventions, such as the Hospital Readmissions
Reduction Program, is the methodology used to risk adjust outcomes. Specifically, the 2 studies published to date
that have questioned the reduction in readmission rates
after the Hospital Readmissions Reduction Program used

logistic regression models to risk adjust readmission rates
for standard demographics, admission dates, and comorbidities.2,3 In contrast, the CMS uses a complex hierarchical logistic regression to calculate a risk-standardized
readmission rate as the ratio of “predicted” over “expected”
readmissions/deaths and then multiplies each hospital’s
ratio by the national unadjusted rate. To date, whether the
2 methodologies produce different results and/or are affected differently by changes in diagnosis codes and the
type of data used has not been explored.
The aim of this study is therefore 2-fold: (1) examine the association between limiting versus not limiting
diagnosis codes and inpatient-
only versus inpatient
and outpatient data with changes in calculated risk-
adjusted 30-day readmission rates and (2) determine
the difference in risk-adjusted readmission rates calculated using standard logistic regression versus the
CMS risk-
standardized methodology and determine
whether they are differentially sensitive to changes in
diagnoses code counts or data sources.

METHODS
This project was reviewed and approved by the
Dartmouth-
Hitchcock Medical Center Institutional
Review Board. This article is compliant with the
Strengthening the Reporting of Observational Studies
in Epidemiology reporting guideline for observational
studies. The authors declare that all supporting data
are available within this article and its online supplementary files. All analyses were performed between
November 2019 and December 2020 using SAS 9.4.

Study Cohorts
We used 100% Medicare Parts A and B and 100%
outpatient data to create 2 cohorts of beneficiaries aged ≥65 years with ≥1 admission for AMI or HF
between 2009 and 2013. Using the CMS published
methodologies, we created an AMI readmission and a
HF readmission cohort (Figure S1).13 Beneficiaries were
required to have 12 months of fee-for-service coverage before their AMI or HF admission. Beneficiaries
with unknown age or sex, those enrolled in Medicare
for <12 months, those discharged against medical
advice, those who died before discharge, and those
who underwent implantation of a left ventricular assist
device or heart transplant during admission or in the
12 months before admission were excluded.14

Calculating Hierarchical Condition
Categories (Comorbidities) for Risk
Adjustment
To determine the number of hierarchical condition
comorbidities (HCCs)15 per patient to include in the
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readmission models, we used the following 4 different
approaches/methods:
1. Inpatient-
only data with diagnostic codes limited
to 9 after 2011.
2. Inpatient-only data with diagnostic codes not limited
after 2011.
3. Inpatient and outpatient data with diagnostic codes
limited to 9 after 2011.
4. Inpatient and outpatient data with diagnostic codes
not limited after 2011.

Risk-Adjusted Readmission Rates
We produced risk-adjusted readmission rates using a
multivariable logistic regression model using all years of
data between 2009 and 2013. The model(s) included
age, sex, race, admission date, HCCs (determined
using each of the 4 methods described previously) and
a year-specific indicator.

Risk-Standardized Readmission Rates
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To calculate the risk-standardized 30-day readmission
rates, we used the CMS methodology. We used hierarchical logistic regression and all years of data between
2009 and 2013 with year-specific indicators to calculate the ratio of the number of “predicted” to the number of “expected” readmissions for each hospital and
then multiplied that ratio by the national unadjusted readmission rate in that year. This approach is analogous
to using a ratio of “observed” to “expected” such that
a lower ratio indicates a lower than expected rate of readmissions/deaths, whereas a higher ratio indicates a
higher than expected rate of deaths.16 For each cohort,
we then calculated the risk-standardized 30-day readmission rate using each of the 4 comorbidity ascertainment methods described previously.17

Statistical Analysis
We analyzed data from January 2009 through
December 2013, 2 years before and 2 years after the diagnosis code expansion in January 2011. We calculated
the mean International Classification of Diseases, Ninth
Revision (ICD-9) counts and HCCs per patient in each
year and report the means and standard deviations for
both AMI and HF. We then determined the absolute
difference in risk-
adjusted/risk-
standardized readmission rates depending on whether diagnosis codes were
limited and whether outpatient data were included. We
compared these differences using chi-square testing.
We then used a difference-in-differences approach to
examine changes in readmission rates from the baseline
period (2009–2011) to the postperiod (2011–2013), depending on whether the ICD-9 codes were limited to 9
and whether outpatient data were included.

Risk-Adjustment Methods for Readmission

RESULTS
Association Between Diagnosis Code
Expansion and Changes in Comorbidity
Burdens
As shown in Figure 1, when the number of diagnosis
codes allowed for inpatient hospitalizations was expanded after 2011, the number of ICD-9 and HCC conditions used for risk adjustment increased for both AMI
and HF, regardless of whether inpatient-only or inpatient and outpatient data were used. The mean number
of diagnosis codes used, at the hospital level, before
and after 2011 show similar increases (Table S1), and
the percentage of patients with 10 or more diagnosis
codes on the index admission claim sharply increased
after 2011, consistent with the abrupt step-up seen in
Figure 1 (Table S2).
With the expansion in the number of allowed inpatient diagnosis codes, after 2011, the number of ICD-9
and HCCs both increased significantly, although the
magnitude of increase was larger for ICD-9 diagnoses
compared with HCCs (Figure 1). For example, in 2011
in the AMI cohort, when inpatient-only data were used,
the average number of ICD-9 diagnoses increased by
5.5 (from 14.1 to 19.6, +39%; P<0.001) and the average number of HCCs increased by 0.4 (from 4.0 to 4.4,
+10%; P<0.001). For the HF cohort, when inpatient-
only data were used, the average number of ICD-9
diagnoses increased by 7.2 (from 18.8 to 26.0, +38%;
P<0.001) and the average number of HCCs increased
by 0.4 (from 4.7 to 5.1, +9%; P<0.001).
The inclusion of outpatient data mitigated the relative increase in both ICD-9 and HCCs, but both increases remained statistically significant (Figure 1).
When inpatient and outpatient data were used, for the
AMI cohort, the average number of ICD-9 diagnoses
increased by 4.3 (from 47.8 to 51.1, +9%; P<0.001) and
the average number of HCCs increased by 0.2 (from
6.2 to 6.4, +3%; P<0.001). For the HF cohort, the number of ICD-9 diagnoses increased by 5.2 (from 62.2 to
67.4, +8%; P<0.001) and the average number of HCCs
increased by 0.2 (from 7.4 to 7.6, +3%; P<0.001). Also
notable, although the number of ICD-9 and HCC conditions stayed relatively flat for AMI between 2009 and
2013, there was a general uptrend in both ICD-9 and
HCC conditions for the HF cohort across the same
time period.

Inclusion of Diagnosis Code Expansion on
Specific HCCs
Next, we determined which HCCs were most likely to be
added to risk-adjustment models when the number of allowed diagnosis codes for inpatient hospitalizations was
expanded. As seen in Table 1, when diagnosis codes
were not limited, using inpatient-only data, dialysis was
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Figure 1. ICD-9 diagnoses and hierarchical condition categories by year, 2009 to 2013.
Estimates and standard deviations are included in Table S2. Consistent with the Centers for Medicare and Medicaid Services
methodology, both the index admission and the year before admission are considered in the calculation of the number if ICD-9
codes and HCCs that should be included in risk adjustment. AMI indicates acute myocardial infarction; HCC, hierarchical condition
comorbidity; HF, heart failure; ICD-9, International Classification of Diseases, Ninth Revision; IP, inpatient; and OP, outpatient.

95% more commonly coded for AMI readmissions and
unspecified heart disease was 122% more commonly
coded for HF readmissions. When inpatient and outpatient data were considered, dialysis was the most commonly added HCC in the AMI readmission cohort (20%
more commonly coded) and nephritis was the most
commonly added HCC in the HF readmission cohort
(44% more commonly coded).

Association Between Diagnosis Code
Expansion and Readmission Rates
Calculated Using Logistic Regression for
Risk Adjustment
Using logistic regression for risk adjustment, between
2009 and 2013, risk-adjusted readmission rates fell for
both AMI and HF (Figure 2). Using inpatient-only data,
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Table 1. Increase in Hierarchical Condition Category Diagnoses Observed When Diagnosis Codes Are Not Limited and
When Outpatient Data Are Included
Inpatient-only data (percent difference)

Inpatient+outpatient data (percent difference)

AMI readmission
Dialysis

95.2

Dialysis

20.4

Urinary tract disease

81.8

History of CABG

17.5

Valvular/rheumatic disease

59.7

Valvular/rheumatic disease

15.3

HF readmission
Unspecified heart disease

122.1

Nephritis

43.9

Nephritis

116.3

Drug, alcohol abuse

31.7

Psychiatric disease

115.0

Depression

30.8

AMI indicates acute myocardial infarction; CABG, coronary artery bypass grafting; and HF, heart failure.
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in 2011, limiting diagnosis codes was not associated
with a difference in 30-day AMI readmission rates (difference, −0.14%; P=0.37) or HF 30-day readmission
rates (difference, −0.04%; P=0.70). By 2013, the difference was slightly larger (for AMI, 0.19% [P=0.20];
for HF, 0.10% [P=0.34]) but remained insignificant
(Table 2).
Using inpatient and outpatient data, in 2011, for
AMI, the difference between limited and unlimited
models was 0.06% (P=0.70; compared with inpatient-
only difference, 0.08%; P<0.001). Using inpatient and
outpatient data, in 2011, for HF, the difference between
limited and unlimited models was was 0.01% (P=0.92;
compared with inpatient-
only difference, 0.03%;
P<0.001). In 2013, the difference between limited and
unlimited models was 0.08% (P=0.59; compared with
inpatient-only difference, 0.11%; P<0.001) and for HF
was 0.02% (P=0.85; compared with inpatient-only difference, 0.08%; P<0.001).

Association Between Diagnosis Code
Expansion and Readmission Rates
Calculated Using the CMS Risk-
Standardization Methodology
For both AMI and HF, the CMS risk-standardized readmission rates were approximately 1% higher than
readmission rates calculated using logistic regression.
Between 2009 and 2013, risk-standardized readmission rates fell for both AMI and HF (Figure 3).
Between 2011 and 2013, when inpatient-only data
or inpatient and outpatient data were used, there
were no significant differences between limited and
unlimited model readmission rates for AMI. For HF,
unlimited model estimates were 0.13% (P=0.04, in
2011) to 0.10% (P=0.04, in 2013) higher. When outpatient data were added, whereas unlimited model
estimates remained higher for HF, the difference was
no longer significant (2011 difference, 0.05% [P=0.42];
2013 difference, 0.04% [P=0.44]). For both AMI and
HF, the difference between limited and unlimited

models was smaller (P<0.001) when outpatient data
were included.

Comparison of Readmission Trends Before
and After 2011 Diagnosis Code Expansion
Using a difference-in-differences approach, we compared risk-standardized readmission rates before versus after the 2011 code expansion using limited versus
unlimited codes in the post-2011 period. For both AMI
and HF, there were no significant differences in estimated readmission rates in the postperiod (2009 versus 2013) based on whether diagnoses codes were
limited or not using both risk-standardized adjustment
(Table 3) and logistic regression adjustment (Table S3).

DISCUSSION
Since 2011, when the CMS increased the number of diagnosis codes that could be submitted for an inpatient
hospitalization, there has been controversy about how
to accurately use claims data to ascertain comorbidities,
longitudinally assess outcomes, and evaluate policies
that span this time period. Consistent with prior work,
this study confirms that to fairly compare the rates of
specific comorbidities before and after 2011, researchers
should consider limiting diagnosis codes after 2011.3,4,18
This work also finds that when possible, outpatient data
should be included to ensure completeness and consistency of comorbidity counts. Although there appear
to be differences in readmission rates for AMI and HF,
depending on whether logistic regression or the CMS
risk-
standardization methodology is used, longitudinal
estimates of changes in risk-adjusted readmission rates
are not affected by the 2011 code expansion, whether
using CMS methods or logistic regression methods, or
whether including or excluding outpatient data.
The first key finding of this work is that when possible, outpatient data should be included to ensure completeness of comorbidity assessment. For AMI, when
diagnosis codes are expanded, “dialysis” was most
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Figure 2. Risk-adjusted readmission rates calculated using logistic regression.
Models are adjusted for age, sex, race, year, and individual hierarchical condition comorbidities.
AMI indicates acute myocardial infarction; HF, heart failure; IP, inpatient; and OP, outpatient.

commonly added and “unspecified heart disease”
and “nephritis” were most commonly added for HF.
Notably, the percentage increase in specific diagnoses was smaller when outpatient data were included,
underscoring how including outpatient data minimizes
the changes associated with diagnosis code limits.
The second key finding of this work is that when
outpatient data are added, the difference between limited and unlimited models for AMI and HF is not significant for either logistic regression or risk-standardized
models. Although prior work has suggested that logistic regression–based risk adjustment may be impacted by the 2011 diagnosis code expansion,2,3 this
work finds that including outpatient data minimizes

any differences in readmission rates associated with
changes in the number of diagnosis codes included.
The third key finding of this work is, when analyzed
longitudinally and using a difference-in-differences analysis, there does not appear to be a significant difference in either logistic regression–adjusted or the CMS
risk-standardized readmission rates trends before and
after the 2011 diagnosis code expansion using either
inpatient-only or inpatient and outpatient data.
Finally, because logistic regression and the CMS
risk-
standardization produce readmission rates that
are ~1% different on average and because these 2
methods may be differentially affected by the 2011
diagnosis code expansion, researchers and policy
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21.80 (21.66–21.80)

21.12 (20.98–21.27)

19.97 (19.82–20.11)

2013

14.69 (14.48–14.90)

2013

2012

16.03 (15.83–16.25)

2012

2011

17.02 (16.80–17.23)

2011

22.10 (22.02–22.18)

20.93 (20.86,21.00)

2012

2013

15.77 (15.73–15.81)

2013

22.78 (22.70–22.86)

17.15 (17.10–17.20)

2012

2011

18.16 (18.10–18.21)

2011

21.03 (20.96,21.10)

22.22 (22.14–22.30)

22.91 (22.82–22.99)

15.78 (15.74–15.83)

17.16 (17.11–17.21)

18.17 (18.12–18.23)

19.87 (19.73–20.02)

21.03 (20.89–21.89)

21.76 (21.62–21.91)

14.50 (14.29–14.71)

15.84 (15.63–16.05)

16.88 (16.67–17.10)

Inpatient unlimited,
percent (95% CI)

AMI indicates acute myocardial infarction; and HF, heart failure.

HF readmissions

AMI
readmissions

Hospital risk-standardized readmission rate

HF readmissions

AMI
readmissions

Risk-adjusted logistic regression models

Inpatient limited,
percent (95% CI)

0.10 (0.04)

0.12 (0.04)

0.13 (0.04)

0.01 (0.67)

0.01 (0.67)

0.01 (0.66)

0.10 (0.34)

0.09 (0.39)

0.04 (0.70)

0.19 (0.20)

0.19 (0.21)

0.14 (0.37)

Inpatient
difference,
percent (P Value)

21.03 (20.96–21.10)

22.21 (22.14–22.29)

22.90 (22.82–22.99)

15.75 (15.71–15.79)

17.13 (17.09–17.18)

18.14 (18.09–18.19)

19.93 (19.79–20.08)

21.09 (20.94–21.23)

21.77 (21.62–21.91)

14.59 (14.39–14.80)

15.94 (15.73–16.15)

16.92 (16.71–17.14)

Inpatient+Outpatient
limited, percent (95%
CI)

21.07 (21.00–21.14)

22.26 (22.18–22.34)

22.95 (22.87–23.03)

15.76 (15.72–15.80)

17.14 (17.09–17.19)

18.15 (18.10–18.20)

19.91 (19.76–20.06)

21.06 (20.92–21.21)

21.76 (21.61–21.90)

14.51 (14.31–14.72)

15.86 (15.65–16.07)

16.86 (16.65–17.08)

Inpatient+Outpatient
unlimited, percent
(95% CI)

0.04 (0.44)

0.05 (0.43)

0.05 (0.42)

0.01 (0.81)

0.01 (0.81)

0.01 (0.80)

0.02 (0.85)

0.03 (0.77)

0.01 (0.92)

0.08 (0.59)

0.08 (0.60)

0.06 (0.70)

Inpatient+Outpatient
difference, percent
(P Value)

0.07 (<0.001)

0.07 (0.001)

0.08 (<0.001)

0.01 (<0.001)

0.01 (<0.001)

0.01 (<0.001)

0.08 (<0.001)

0.06 (<0.001)

0.03 (<0.001)

0.11 (<0.001)

0.11 (<0.001)

0.08 (<0.001)

Inpatient
difference vs
Inpatient+Outpatient
difference, percent
(P Value)

Table 2. Comparing the Association Between Diagnosis Code Expansion and Risk-Adjusted Logistic Regression Readmission Models Versus the Centers for Medicare
and Medicaid Services Risk-Standardized Readmission Models

Gilstrap et al
Risk-Adjustment Methods for Readmission
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Figure 3. Risk-standardized readmission rates calculated using the Centers for Medicare and Medicaid Services published
methodology.
AMI indicates acute myocardial infarction; HF, heart failure; IP, inpatient; and OP, outpatient.

makers should use caution when comparing the results of studies that use different analytic methods.
These results highlight important considerations for
comparing the evaluations of policies that span 2011,
specifically the following:

1. Researchers may want to consider limiting diagnosis codes to 9 to allow a fair comparison of
comorbidity counts over time.
2. When outpatient data are included, diagnosis code
limits do not appear to significantly affect readmission

Table 3. Difference in Differences Analysis Comparing Risk-Standardized Readmission Trends Before Versus After the
2011 Diagnosis Code Expansion Using 9 Versus 25 Codes in the Post-2 011 Period
2009 Risk-standardized
readmission rate LS mean (95% CI)

2013 Risk-standardized readmission
rate LS mean (95% CI)

LS mean P
Value

P Value for
interaction

AMI, limited

0.189 (−0.181 to 0.559)

0.157 (−0.151 to 0.465)

0.189

0.88

AMI, unlimited

0.189 (−0.182 to 0.560)

0.157 (−0.151 to 0.466)

0.189

HF, limited

0.235 (−0.226 to 0.696)

0.206 (−0.197 to 0.609)

0.74

HF, unlimited

0.235 (−0.226 to 0.696)

0.206 (−0.198 to 0.610)

0.48

AMI, limited

0.189 (−0.181 to 0.559)

0.157 (−0.151 to 0.465)

0.94

AMI, unlimited

0.189 (−0.182 to 0.560)

0.157 (−0.151 to 0.466)

0.96

HF, limited

0.235 (−0.226 to 0.696)

0.206 (−0.198 to 0.609)

0.90

HF, unlimited

0.235 (−0.226 to 0.697)

0.206 (−0.198 to 0.609)

0.81

Inpatient-only data

0.38

Inpatient+outpatient data
0.38

0.77

AMI indicates acute myocardial infarction; HF, heart failure; and LS, least squares.
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rate estimates from either logistic regression or risk-
standardized models.
3. When analyzed longitudinally, there does not appear to be a significant difference in either logistic
regression–adjusted or the CMS risk-standardized
readmission rates trends before and after the 2011
based on whether diagnosis codes are limited or
whether inpatient-
only or inpatient and outpatient
data are used.
4. Caution should be used when comparing analyses
that use logistic regression to studies that use risk
standardization to compare risk-adjusted outcomes.

Risk-Adjustment Methods for Readmission
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Limitations

Supplementary Material

This study is unique to the Medicare population of patients hospitalized with AMI or HF and the Medicare
risk-adjustment algorithms used for these 2 conditions.
Thus, caution should be used when extrapolating the
findings to other patient groups and/or risk-adjustment
algorithms. In addition, this study does not use a control group to formally evaluate longitudinal estimates
using 9 versus 25 diagnosis codes nor does it formally
compare estimates using inpatient-only versus inpatient and outpatient data. Although limiting to the first
9 diagnosis codes is a methodology demonstrated in
previous studies, this does introduce potential arbitrariness because we have no knowledge about the ordering of the conditions listed. Typically, medical coders
list comorbidities in order of priority based on likely
reimbursement, but this may not always be the case.

Tables S1–S3
Figures S1

CONCLUSIONS
For studies that span January 2011, researchers may
want to consider limiting diagnosis codes to 9 to allow
a fair comparison of comorbidity counts over time.
In addition, outpatient data should be included when
available to ensure completeness of comorbidity assessment. At the same time, researchers do not need
to restrict to 9 codes or include outpatient data for
analyses of risk-adjusted readmission rates before and
after 2011.
Although the 2011 diagnosis code expansion and
the inclusion of outpatient data do not appear to significantly impact risk-
adjusted readmission rates for
AMI or HF, when comparing studies that evaluate
policies spanning 2011, is it important for readers, researchers, and policy makers to note the methodology
used. Direct comparison of studies that use different
risk-adjustment methodologies may be problematic.
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Figure S1. Consort Diagrams for 2 Cohorts.
AMI Risk Standardized Readmission Cohort Data Flow Diagram: 2009 - 2013
MEDPAR AMI Admissions
Index Cohort
(hospitalizations with principal AMI
Dx)
for 2009 - 2013
Dataset n = 1,462,839

Exclusions

Index Admission

n = 693,776
non-FFS (n = 387,172)
non-FFS post (n = 397,509)
Discharge <= 1 day (n=137,173)
Died (n = 113,251)
Transferred status (n = 67,471)
Age < 66 (n = 29,001)
CMS Hospice (n = 10,678)
Discharge AMA (n = 6,372)
Missing data (n = 58)

n = 769,063

Initial Cohort
365 day lookback with:
(IP admit + OP + Part B)

n = 612,940
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Study Cohort
365 day lookback with:
(IP admit + OP + Part B)
Hospital Volume > 10
n = 578,728

HF Risk Standardized Readmission Cohort Data Flow Diagram: 2009 - 2013
MEDPAR HF Admissions
Index Cohort
(hospitalizations with principal HF
Dx)
for 2009 - 2013
Dataset n = 3,075,536

Index Admission
n = 1,819,103

Initial Cohort
365 day lookback with:
(IP admit + OP + Part B)

n = 1,617,593
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Study Cohort
365 day lookback with:
(IP admit + OP + Part B)
Hospital Volume > 10
n = 1,595,069

Exclusions
n = 1,256,433
non-FFS (n = 809,822)
non-FFS post (n=718,139)
Died (n = 116,658)
Transferred status (n =
76,193)
Age < 66 (n = 36,294)
LVAD / transplant (n =
18,805)
Discharge AMA (n = 12,547)

Table S1. Average Field Counts used to Count ICD-9 Before/After 2011.
2009

AMI
Readmissions

n (hospitals)
n (patients)
mean
median
std dev
min
max

HF
Readmissions

n (hospitals)
n (patients)
mean
median
std dev
min
max

IP
(first 9)
1998
116850
14.2
9.0
8.8
1.0
98.0
3829
346730
18.7
16.0
10.4
1.0
95.0

2010
IP+OP
(first 9)
1998
116850
46.5
41.0
25.5
2.0
265.0
3829
346730
59.6
55.0
28.2
3.0
253.0

IP
(first 9)
1998
116070
14.1
9.0
8.8
1.0
96.0
3770
332725
18.6
16.0
10.4
1.0
104.0

2011
IP+OP
(first 9)
1998
116070
47.4
42.0
26.0
3.0
239.0
3770
332725
61.0
56.0
28.7
4.0
276.0

IP
(first 9)
1982
115887
14.1
9.0
8.8
1.0
94.0
3670
317961
18.8
16.0
10.4
1.0
99.0
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2012

AMI
Readmissions

n (hospitals)
n (patients)
mean
median
std dev
min
max

HF
Readmissions

n (hospitals)
n (patients)
mean
median
std dev
min
max

IP
(first 9)
1954
117697
14.0
9.0
8.7
1.0
100.0
3581
304913
18.8
16.0
10.5
1.0
95.0

IP (no
limit)
1954
117697
20.9
17.0
14.1
1.0
149.0
3581
304913
28.7
25.0
16.5
1.0
155.0

IP (no
limit)
1982
115887
19.6
17.0
12.4
1.0
137.0
3670
317961
26.0
23.0
14.3
1.0
141.0

IP+OP
(first 9)
1982
115887
47.8
42.0
26.2
3.0
237.0
3670
317961
62.2
58.0
29.2
3.0
265.0

IP+OP
(no
limit)
1982
115887
52.1
46.0
28.1
3.0
248.0
3670
317961
67.4
63.0
31.1
3.0
293.0

IP+OP
(first 9)
1910
112224
48.7
43.0
26.6
3.0
235.0
3463
292740
63.8
59.0
29.7
4.0
276.0

IP+OP
(no
limit)
1910
112224
54.4
48.0
29.8
3.0
281.0
3463
292740
71.6
66.0
33.3
4.0
299.0

2013
IP+OP
(first 9)
1954
117697
48.4
43.0
26.6
4.0
252.0
3581
304913
63.2
59.0
29.6
4.0
277.0

IP+OP
(no
limit)
1954
117697
53.8
47.0
29.6
4.0
281.0
3581
304913
70.4
65.0
33.0
4.0
298.0

IP
(first 9)
1910
112224
13.8
9.0
8.6
1.0
84.0
3463
292740
18.6
16.0
10.4
1.0
93.0

IP (no
limit)
1910
112224
21.2
17.0
14.3
1.0
145.0
3463
292740
29.3
25.0
16.8
1.0
148.0

Table S2. Average Index Claim Counts Before/After 2011.
Year

2009
2010
2011
2012
2013

AMI Index
Claim
n
116,850
116,070
115,887
117,697
112,224

9 or more
diagnosis
codes
79.5%
80.0%
81.0%
82.1%
83.0%

10 or more
diagnosis
codes
8.1%
4.6%
73.1%
75.1%
76.7%

HF Index
Claim
n
346,730
332,725
317,961
304,913
292,740

9 or more
diagnosis
codes
85.3%
87.1%
89.2%
90.7%
92.2%

10 or more
diagnosis
codes
6.0%
4.7%
81.9%
85.0%
87.7%
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Table S3. Difference in Differences Analysis Comparing Logistic Regression Adjusted Readmission Trends Before vs. After the 2011 Diagnosis
Code Expansion using 9 vs 25 codes in the Post-2011 Period.
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2009 RiskStandardized
Readmission Rate
LS Mean

2013 RiskStandardized
Readmission Rate
LS Mean

InpatientOnly,
Limited
Difference

InpatientOnly,
Unlimited
Difference

(Difference in
Differences)

Inpatient-Only Data
AMI (limited)
AMI (unlimited)

0.178
0.179

0.147
0.145

0.031

0.034

1.0

HF (limited)
HF (unlimited)

0.229
0.229

0.199
0.200

0.029

0.031

1.0

2013 RiskStandardized
Readmission Rate
LS Mean

Inpatient+
Outpatient,
Limited
Difference

Inpatient+
Outpatient,
Unlimited
Difference

P-Value for
Interaction
(Difference in
Differences)

0.1460
0.145

0.031

0.032

1.0

0.199
0.199

0.029

0.029

1.0

2009 RiskStandardized
Readmission Rate
LS Mean
Inpatient+Outpatient Data
AMI (limited)
0.177
AMI (unlimited)
0.177
HF (limited)
HF (unlimited)

0.228
0.228

P-Value for
Interaction

